Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.50
Bid: 97.00
Ask: 100.00
Change: 0.50 (0.51%)
Spread: 3.00 (3.093%)
Open: 98.00
High: 98.50
Low: 98.00
Prev. Close: 98.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

Wed, 23rd Feb 2022 20:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Begbies Traynor Group PLC - Manchester-based corporate rescue and recovery company - Says its third quarter which ended January 31 had performed broadly in line with the first half. As a result, Begbies Traynor expects the full-year to be within the range of market expectations and significantly ahead of last year. Current market expectations for pretax profit are in the range of GBP17.0 million to GBP18.5 million. Reports insolvency numbers have returned to pre-pandemic levels due to increased liquidations.

----------

Gooch & Housego PLC - Somerset, England-based photonics company - Reports strong and improving levels of overall demand in the first four months of its financial year which ends September 30. The company reports a record order book of GBP110.5 million at January 31, up 16% from GBP95.0 million at the same time the previous year. Notes high demand for industrial lasers. Expects trading to have a slightly higher second half weighting than anticipated but says full-year outlook remains unchanged.

----------

Great Western Mining Corp PLC - London-based mineral exploration and development company with operations in the US - Says 51 mineralised spoil heaps have now been located at Mineral Jackpot in Nevada, US. Notes average grades of vein material of 1.57 grams per tonne of gold and average grades of altered wall rock of 0.04 grams per tonne of gold. Says spoil heaps were composed of average 5% vein material and 50% altered wall rock. Chair Brian Hall calls the results "highly encouraging".

----------

Union Jack Oil PLC - Bath, England-based oil and gas company with operations across the UK - Says it intends to adopt a capital allocation and distribution policy to allow the payment of a dividend or implement a share repurchase programme. This comes as a result of its current performance, principally at the Wressle development, the company explains.

----------

BiVictriX Therapeutics PLC - Cheshire, England-based biotechnology company - Expands its therapeutic pipeline with two additional programmes, BVX002 and BVX003. BVX002 and BVX003 target novel cancer-specific twin antigen fingerprints and enable the targeting of several haematological and solid tumour cancer indications. Both are entering the early stages of drug development.

----------

Okyo Pharma Ltd - London-based biopharmaceutical company focused on eye diseases and ocular pain - Receives patent from the US Patent & Trademark Office covering OK-101 to treat neuropathic pain. OK-101 is the company's anti-inflammatory drug being developed to treat dry eye disease. Adds the drug is expected to begin a phase two clinical trial in the fourth quarter of 2022.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical company - Announces updated survival data from its phase one/two study investigating the safety and efficacy of bexmarilimab. Bexmarilimab is an investigative immunotherapy with the potential to provide immune stimulation for difficult-to-treat cancers, Faron explains. Study demonstrates an estimated median progression free survival of 59 days and an estimated median overall survival of 157 days. Chief Medical Officer Marie-Louise Fjallskog says the data shows late-stage cancer patients who receive clinical benefit from bexmarilimab can "achieve long term survival".

----------

Chesterfield Resources PLC - London-based gold and copper company operating in Canada and Cyprus - Says drilling at its Troodos West project in Cyprus has significantly enhanced the prospectivity at three target areas, Orchard, Evlim and Evlim South, and has also established a 12 kilometre geological trend that the company considers key to controlling several mineralised systems. Adds that this 12 kilometre trend, named the Westline Trend, will now be the focus of its 2022 exploration campaign, due to commence shortly.

----------

Invinity Energy Systems PLC - London-based energy storage company - Wins GBP708,371 of funding from the UK Department for Business, Energy & Industrial Strategy for the Longer Duration Energy Storage Demonstration competition. The award will fund a comprehensive planning and feasibility study on what Invinity says could become one of the UK's largest co-located solar and energy storage projects. Work on the phase one feasibility study has already commenced and is expected to progress throughout 2022, the company adds.

----------

Technology Minerals PLC - London-based battery metals company - Says its wholly-owned subsidiary, Technology Minerals Cameroon Ltd, has applied for five exploration permits in Cameroon. The company says it has now received copies of all these permits and has instructed Technology Minerals Cameroon's legal counsel to verify the validity of the permits.

----------

Sanderson Design Group PLC - Buckinghamshire, England-based luxury interior furnishings company - Announces that its brand Morris & Co is launching a second collection of fabrics and wallpapers in collaboration with architect and designer Ben Pentreath. The collection will launch in March.

----------

Mirriad Advertising PLC - London-based advertising company - Signs partnership with unnamed company which it describes as "Canada's largest TV and digital media conglomerate". Says the partnership is strategically important for the North American market. Does not disclose financial details of the partnership. Mirriad adds that US campaign revenues were up by over 800% during the 2021 holiday season compared to 2020.

----------

SEEEN PLC - London-based AI-focused media platform - Forms strategic partnership with Auckland-based media intelligence platform Kinetiq Inc. The companies plan to provide "end-to-end" solutions for brands, networks and publishers to better manage and measure audience experiences, SEEEN explains.

----------

Cohort PLC - Reading, England-based - Says that its SEA subsidiary has been appointed to supply its torpedo launcher systems to South Korea-based ship building company Hyundai Heavy Industries Co Ltd. Says the multi-million pound contract will see the first Philippine Navy corvette delivered in 2023 and the second in 2025.

----------

Arena Events Group PLC - St Ives, England-based events management company - Acquisition by IHC Industiral Holding LLC and Tasheel Holding Group LLC completes. Shares in Arena were subsequently suspended.

----------

Drax Group PLC - Yorkshire, England-based power generation company - Provisionally secures agreements to provide 621 megawatts of capacity from its pumped storage and hydro assets. Drax says agreements are at the price of GBP30.59 per kilowatt for the period between October 2025 to September 2026. Expects income of GBP18 million for that period. Adds these agreements are in addition to its existing agreements.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Says that First Development Resources Ltd, a company in which Power Metal holds a 83% interest, has received notification from the Northern Territory Government Department of Industry, Tourism & Trade that all three Selta project mineral exploration licences have now been granted for a term of six years. The Selta project is located in Australia's Northern Territory and has been declared prospective for uranium mineralisation.

----------

Curzon Energy PLC - London-based energy company - Refinances and extends the outstanding loan between itself and Redcar, England-based chemical recycling company Poseidon Plastics Ltd. On February 3, a loan agreement of GBP500,000 was made available and due for repayment on February 14. Companies agree to increase the size of the loan facility by GBP245,000 and to refinance all outstanding amounts to February 14, 2023.

----------

Schroder UK Public Private Trust PLC - London-based investment company - Says its portfolio company Atom Bank has raised more than GBP75 million in new equity priced at 70 pence per share. Says this aids company as it grows its profitability and drives towards an IPO. The impact of the funding round will also be reflected in Schroder's next net asset value update, due in April.

----------

Amur Minerals Corp - Khabarovsk, Russia-based nickel copper sulphide mineral exploration company focused in Russia - Says that there is no impact on its operations or activities within Russia following a review of UK and US sanction documentation. Adds that no individual or entity identified within the documents is associated with the company in any way.

----------

Pembridge Resources PLC - London-based mining company with operations in Canada - Says Minto Metals Corp, a company it acquired in 2019, has received a new exploration permit. The 10-year class four quartz mining land use permit was granted by the Yukon Government in Canada. The permit enables Minto to diamond drilling, geophysical surveys and other associated exploration land-use activities on its mining claims, including the Minto Mine property. Adds that Minto has recently approved a CAD9.2 million - around USD7.2 million - exploration programme for 2022.

----------

Avon Protection PLC - Wiltshire, England-based respiratory protection equipment company - Reports that Non-Executive Director Bruce Thompson buys 5,000 shares at a price of GBP10.089 each. Purchase totals GBP50,445.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Nov 2019 12:56

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Read more
8 Nov 2019 10:30

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

Read more
7 Nov 2019 17:59

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Read more
1 Nov 2019 16:58

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

Read more
1 Nov 2019 15:32

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Read more
9 Oct 2019 14:05

Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced feedback from the 'MATINS' study data monitoring committee on Wednesday, from the ongoing dose escalation study from part 1 of the MATINS trial.

Read more
9 Oct 2019 09:18

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Read more
2 Oct 2019 14:57

Faron Pharmaceuticals hits bump in road for Traumakine manufacturing

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that, further to its update in its interim results in relation to the active pharmaceutical ingredient (API) manufacturing process for 'Traumakine', Rentschler Biopharma has sent Faron a letter in which it terminated the agreement concerning the API manufacturing.

Read more
2 Oct 2019 13:13

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Read more
23 Sep 2019 11:37

Faron Pharmaceuticals Ends Traumakine Trial; Loss Narrows On Expenses

(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm

Read more
16 Sep 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 17 September JTCHalf Year ResultsStafflineHalf Year GroupHalf Year Year

Read more
27 Aug 2019 16:34

Faron Pharma raises ?2.3m to keep it going through the start of 2020

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has received valid acceptances and excess applications from qualifying shareholders for a total of 859,513 open offer shares, raising gross proceeds of around €1.01m (£0.92m) at the issue price of 106p per share and at the euro issue price of 119 cents per share, it announced on Tuesday.

Read more
27 Aug 2019 11:38

Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020

(Alliance News) - Faron Pharmaceuticals Oy on Tuesday said it has raised EUR2.5 million via share subscription and open offer.The company raised EUR1.0 million from the issue of 859,513 at

Read more
5 Aug 2019 12:26

Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development

(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical development of cancer drug Clevegen.Shares in

Read more
12 Jul 2019 10:35

WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP up 1.5%. The -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.